RSSCategory: Pharmaceuticals

Indonesia first to approve use of Chinese COVID-19 vaccine

September 30, 2022

Indonesian Food and Drugs Agency (BPOM) has granted approval for the use of an mRNA COVID-19 vaccine developed by a Chinese company, Walvax Biotechnology. Indonesia thus becomes the first country to grant emergency use approval for that vaccine, ahead of even China. Indonesia has gone ahead with the approval despite unpublished efficacy readings for Walvax’s […]

Continue Reading

Novavax’s COVID shot open for adolescents, CDC says

August 23, 2022

Novavax Inc.’s (Novavax) protein-based COVID-19 vaccine has been approved for use in adolescents between 12 to 17 years old, the US Centers for Disease Control and Prevention (CDC) announced on Monday. It was just last week that the vaccine received authorisation from the US Food & Drug Administration (FDA) for its use for the same […]

Continue Reading

Tumour destroyed in days in mice implanted with “drug factory” beads

August 23, 2022

Specially-developed “drug factory” beads continually generate a type of protein that helps eradicate cancerous tumours: scientists at Rice University in Texas, US, noticed that mice implanted with the drug factory beads were soon free of mesothelioma cancer growths, a very aggressive type of cancer that forms in the tissue lining around internal organs. The drug […]

Continue Reading

Flu vaccine protective against Alzheimer’s disease

July 4, 2022

Researchers from the University of Texas Health Science Center at Houston (UT Health Houston) have found that older adults vaccinated at least once against influenza (flu) were 40% less likely to develop Alzheimer’s disease than their non-vaccinated peers. This protective effect was strengthened following an annual flu vaccine shot, said Dr. Avram Bukhbinder, a neurology […]

Continue Reading

Trial of a novel influenza vaccine commences at NIH

July 1, 2022

A promising influenza vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases (NIAID) is now entering a Phase 1 clinical trial which will see up to 100 healthy adult volunteers inoculated. The vaccine is to be delivered either as a nasal spray or by intramuscular injection. The vaccine candidate known as […]

Continue Reading

Experimental dengue vaccine provides immunity for over four years

June 16, 2022

A dengue vaccine candidate developed by Takeda Pharmaceutical (Takeda), TAK-003, has shown promising results in a Phase 3 trial, providing continued protection against dengue fever through 4.5 years (54 months) post-vaccination. Data revealed TAK-003 prevented 61% of symptomatic dengue cases and 84% of hospitalised cases with no important safety risks identified in a trial known […]

Continue Reading

Complete cancer remission in drug trial development

June 8, 2022

A small clinical trial of the drug dostarlimab in the US has virtually rid each of its 18 participants of colorectal cancer, one of the most dangerous common cancers known to man. Doctors, stunned with the effectiveness of the drug, are now expanding the trial to include gastric, prostate, and pancreatic cancer patients. Dostarlimab (TSR-042) […]

Continue Reading

Dual-action drug treats diabetes and obesity

May 17, 2022

A new type of treatment called the Mounjaro (tirzepatide) shot has just been approved by the US Food and Drug Administration (FDA) for type 2 diabetes. The once-weekly injection for adults was found to be effective at controlling blood sugar levels and – in some cases – obesity. Mounjaro was developed to mimic a hormone […]

Continue Reading

EU drug regulator hopes for approval for adaptive coronavirus vaccines this year

May 10, 2022

The European Medicines Agency (EMA) is hoping to have access to multi-protection vaccines, including one that is able to address several coronavirus variants, by September 2022. Vaccine developers are currently investigating whether shots that target just one variant offer advantages over vaccines that target two variants, said Marco Cavaleri, Head of Biological Health Threats and […]

Continue Reading

Pfizer’s potent antiviral treatment endorsed by WHO

April 22, 2022

The World Health Organization (WHO) has backed the use of Pfizer Inc’s (Pfizer) oral COVID-19 antiviral treatment, Paxlovid, in high-risk patients in the early stages of the disease, to avoid hospitalisation. However, WHO is quick to mention that existing COVID-19 treatments including intravenous and antibody treatments, are not to replace vaccination. The recommendation by WHO […]

Continue Reading